[1] P. P. Mortimer, “Was encephalitis lethargica a post-influenzal or another phenomenon? Time to re-examine the issue,” Epidemiology and An infection, vol. 137, no. 4, pp. 449–455, Apr. 2009. doi: 10.1017/S0950268808001891.
[2] R. C. Dale, A. J. Church, R. A. H. Surtees, A. J. Lees, J. E. Adcock, B. Harding, B. G. R. Neville, and G. Giovannoni, “Encephalitis lethargica syndrome: 20 new circumstances and proof of basal ganglia autoimmunity,” Mind, vol. 127, no. 1, pp. 21–33, Jan. 2004. doi: 10.1093/mind/awh008.
[3] M. Brainin, Y. Teuschl, and E. Gelpi, “‘Spanish flu,’ encephalitis lethargica, and COVID-19: Progress made, classes discovered, and instructions for future analysis,” European Journal of Neurology, vol. 31, no. 11, p. e16312, Nov. 2024. doi: 10.1111/ene.16312.
[4] J. P. Rogers, T. Mastellari, A. J. Berry, Ok. Kumar, E. Burchill, A. S. David, G. Lewis, and M. S. Zandi, “Encephalitis lethargica: medical options and aetiology,” Mind Communications, vol. 6, no. 5, p. fcae347, 2024. doi: 10.1093/braincomms/fcae347.
[5] A. Giordano, G. Schwarz, L. Cacciaguerra, F. Esposito, and M. Filippi, “COVID-19: Can we study from encephalitis lethargica?,” The Lancet Neurology, vol. 19, no. 7, p. 570, Jul. 2020. doi: 10.1016/S1474-4422(20)30149-0.
